0519621 - ÚOCHB 2020 RIV eng P - Patentový dokument
Hocek, Michal - Tichý, Tomáš - Hajdúch, M. - Džubák, P.
Substituted thienopyrrolopyrimidine ribonucleosides for therapeutic use.
2019. Vlastník: Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Palackého v Olomouci. Datum udělení patentu: 17.09.2019. Číslo patentu: US10414788
Grant CEP: GA ČR(CZ) GA16-00178S; GA TA ČR(CZ) TE01020028; GA MZd(CZ) NV15-31984A
Institucionální podpora: RVO:61388963
Klíčová slova: nucleosides * fused heterocycles * cytostatics
Obor OECD: Medicinal chemistry
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190917&DB=&locale=en_EP&CC=US&NR=10414788B2&KC=B2&ND=4#

A group of substituted thienopyrrolopyrimidine ribonucleosides of general formula I, in which R shows strong cytostatic and cytotoxic activities preferably against cancer cell lines of broad spectrum of diseases including tumors of various histogenetic origin.
Trvalý link: http://hdl.handle.net/11104/0305071